Update: J&J COVID vaccine rollout paused as clot concerns spreadUS health authorities have recommended pausing dosing with Johnson & Johnson’s COVID-19 vaccine as they investigate cases of Share XUpdate: J&J COVID vaccine rollout paused as clot concerns spreadhttps://pharmaphorum.com/news/us-seeks-halt-on-jj-covid-vaccine-rollout-as-clot-concerns-spread/
Cytisinicline – the solution to stop smoking?Whether present in electronic or combustible cigarettes, nicotine is a highly addictive substance. Dr Cindy Jacobs, chief medical Share XCytisinicline – the solution to stop smoking?https://pharmaphorum.com/views-and-analysis/the-need-for-nicotine-vaping-cessation-therapies/
The power of communication: engaging diverse groups in healthcareHumans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to Share XThe power of communication: engaging diverse groups in healthcarehttps://pharmaphorum.com/views-and-analysis/the-power-of-communication-engaging-diverse-groups-in-healthcare/
UK will offer under-30s alternative to AZ’s COVID jabThe UK drugs regulator has said people aged under 30 should be offered an alternative to the AstraZeneca Share XUK will offer under-30s alternative to AZ’s COVID jabhttps://pharmaphorum.com/news/uk-will-offer-under-30s-alternative-to-azs-covid-jab/
Paediatric trial of AZ COVID jab ‘halted as a precaution’Oxford University has suspended a clinical trial of its AstraZeneca-partnered COVID-19 vaccine in children and adolescents while a Share XPaediatric trial of AZ COVID jab ‘halted as a precaution’https://pharmaphorum.com/news/paediatric-trial-of-az-covid-jab-halted-as-a-precaution/
Could Moderna shot save UK’s under-50s COVID vaccination push?People in the UK will start receiving doses of Moderna’s COVID-19 vaccine in around two weeks’ time, according Share XCould Moderna shot save UK’s under-50s COVID vaccination push?https://pharmaphorum.com/news/could-moderna-shot-save-uks-under-50s-covid-vaccination-push/
EMA backs safety of AZ COVID-19 jab in all age groupsThe head of the EMA has reiterated that there is no evidence to limit the use of AstraZeneca’s Share XEMA backs safety of AZ COVID-19 jab in all age groupshttps://pharmaphorum.com/news/ema-backs-safety-of-az-covid-19-jab-in-all-age-groups/
UK government launches new office to “level up” nation’s healthThe government has continued its shake-up of UK health authorities with the creation of the Office of Health Share XUK government launches new office to “level up” nation’s healthhttps://pharmaphorum.com/news/no-10-launches-new-office-to-level-up-nations-health/
MHRA launches patient involvement pilot for drug applicationsThe UK drugs regulator is now asking that all applications for new medicines or indications detail the efforts Share XMHRA launches patient involvement pilot for drug applicationshttps://pharmaphorum.com/news/mhra-launches-patient-centric-pilot-for-drug-applications/
